Palantir Technologies Inc. Equity Method Investments increased by 32.8% to $163.20M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 210.3%, from $52.60M to $163.20M.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|
| Value | $32.60M | $35.10M | $49.90M | $52.60M | $64.90M | $104.50M | $122.90M | $163.20M |
| QoQ Change | — | +7.7% | +42.2% | +5.4% | +23.4% | +61.0% | +17.6% | +32.8% |
| YoY Change | — | — | — | — | +99.1% | +197.7% | +146.3% | +210.3% |
We use cookies for analytics. See our Privacy and Cookie Policy.